Literature DB >> 1663950

Modification of transplasma membrane oxidoreduction by SV40 transformation of 3T3 cells.

H Löw1, F L Crane, C Grebing, M Isaksson, A Lindgren, I L Sun.   

Abstract

Transformation of 3T3 cells by SV40 virus changes the properties of the transplasma membrane electron transport activity which can be assayed by reduction of external ferric salts. After 42 h of culture and before the growth rate is maximum, the transformed cells have a much slower rate of ferric reduction. The change in activity is expressed both by change in Km and Vmax for ferricyanide reduction. The change in activity is not based on surface charge effect or on tight coupling to proton release or on intracellular NADH concentration. With transformation by SV40 virus infection the expression of transferrin receptors increases, which correlates with greater diferric transferrin stimulation of the rate of ferric ammonium citrate reduction in transformed SV40-3T3 cells than in 3T3 cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1663950     DOI: 10.1007/bf00786008

Source DB:  PubMed          Journal:  J Bioenerg Biomembr        ISSN: 0145-479X            Impact factor:   2.945


  40 in total

1.  Identification of transferrin receptors on the surface of human cultured cells.

Authors:  T A Hamilton; H G Wada; H H Sussman
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

2.  Transplasmalemma electron transport is changed in simian virus 40 transformed liver cells.

Authors:  I L Sun; P Navas; F L Crane; J Y Chou; H Löw
Journal:  J Bioenerg Biomembr       Date:  1986-12       Impact factor: 2.945

3.  Growth and maintenance of HeLa cells in serum-free medium supplemented with hormones.

Authors:  S E Hutchings; G H Sato
Journal:  Proc Natl Acad Sci U S A       Date:  1978-02       Impact factor: 11.205

4.  The growth stimulation of SV3T3 cells by transferrin and its dependence on biotin.

Authors:  D V Young; F W Cox; S Chipman; S C Hartman
Journal:  Exp Cell Res       Date:  1979-02       Impact factor: 3.905

Review 5.  Extracellular control of erythrocyte metabolism mediated by a cytoplasmic tyrosine kinase.

Authors:  P S Low; R L Geahlen; E Mehler; M L Harrison
Journal:  Biomed Biochim Acta       Date:  1990

6.  Modification of transmembrane electron transport activity in plasma membranes of simian virus 40 transformed pineal cells.

Authors:  I L Sun; F L Crane; J Y Chou
Journal:  Biochim Biophys Acta       Date:  1986-05-29

7.  NADH diferric transferrin reductase in liver plasma membrane.

Authors:  I L Sun; P Navas; F L Crane; D J Morré; H Löw
Journal:  J Biol Chem       Date:  1987-11-25       Impact factor: 5.157

8.  Ferricyanide can replace pyruvate to stimulate growth and attachment of serum restricted human melanoma cells.

Authors:  K A Ellem; G F Kay
Journal:  Biochem Biophys Res Commun       Date:  1983-04-15       Impact factor: 3.575

9.  Involvement of transferrin in the reduction of iron by the transplasma membrane electron transport system.

Authors:  H Löw; C Grebing; A Lindgren; M Tally; I L Sun; F L Crane
Journal:  J Bioenerg Biomembr       Date:  1987-10       Impact factor: 2.945

10.  Effects of anti-transferrin receptor antibodies on growth of normal and malignant myeloid cells.

Authors:  R Taetle; J M Honeysett; I Trowbridge
Journal:  Int J Cancer       Date:  1983-09-15       Impact factor: 7.396

View more
  3 in total

1.  Ehrlich cell plasma membrane redox system is modulated through signal transduction pathways involving cGMP and Ca2+ as second messengers.

Authors:  A del Castillo-Olivares; A Esteban del Valle; J Márquez; I Núñez de Castro; M A Medina
Journal:  J Bioenerg Biomembr       Date:  1995-12       Impact factor: 2.945

2.  Iron reverses impermeable chelator inhibition of DNA synthesis in CCl 39 cells.

Authors:  F J Alcain; H Löw; F L Crane
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-16       Impact factor: 11.205

3.  The oxidative function of diferric transferrin.

Authors:  Frederick L Crane; Hans Löw
Journal:  Biochem Res Int       Date:  2012-02-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.